SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 148,711.01 |
Enterprise Value ($M) | 212,738.01 |
Book Value ($M) | 92,558.00 |
Book Value / Share | 16.33 |
Price / Book | 1.61 |
NCAV ($M) | -74,541.00 |
NCAV / Share | -13.15 |
Price / NCAV | -2.00 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.05 |
Return on Assets (ROA) | 0.04 |
Return on Equity (ROE) | 0.08 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.92 |
Current Ratio | 1.17 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 50,358.00 |
Assets | 213,396.00 |
Liabilities | 124,899.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 63,627.00 |
Operating Income | 16,328.00 |
Net Income | 8,031.00 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 12,744.00 |
Cash from Investing | 2,652.00 |
Cash from Financing | -17,140.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Vanguard Group Inc | 8.97 | 0.97 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
8,801,874 | 48,219,947 | 18.25 | |
7,049,468 | 35,638,777 | 19.78 | |
5,184,954 | 30,250,360 | 17.14 | |
8,774,275 | 37,170,828 | 23.61 | |
9,251,093 | 43,937,593 | 21.06 | |
(click for more detail) |
Similar Companies | |
---|---|
NUVB – Nuvation Bio Inc. | OGN – Organon & Co. |
PBH – Prestige Consumer Healthcare Inc. | PRGO – Perrigo Company plc |
QGEN – Qiagen N.V. |
Financial data and stock pages provided by
Fintel.io